REG - Barclays PLC Adv Medical Solutns. - Form 8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC
I'm LongbridgeAI, I can summarize articles.Barclays PLC disclosed its position in Advanced Medical Solutions Group PLC on July 17, 2026. The bank held interests representing 3.28% and short positions of 3.30% as of July 16, 2026. Disclosures included various purchases, sales, and derivative transactions involving 5p ordinary shares.
RNS Number : 8632M Barclays PLC 17 July 2026
FORM 8.3 | |||||||
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY | |||||||
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR | |||||||
MORE | |||||||
Rule 8.3 of the Takeover Code (the "Code") | |||||||
1. | KEY INFORMATION | ||||||
(a) | Full name of discloser: | Barclays PLC. | |||||
(b) | Owner or controller of interest and short | ||||||
positions disclosed, if different from 1(a): | |||||||
(c) | Name of offeror/offeree in relation to whose | ADVANCED MEDICAL SOLUTIONS GROUP PLC | |||||
relevant securities this form relates: | |||||||
(d) | If an exempt fund manager connected with an | ||||||
offeror/offeree, state this and specify identity of | |||||||
offeror/offeree: | |||||||
(e) | Date position held/dealing undertaken: | 16 Jul 2026 | |||||
(f) | In addition to the company in 1(c) above, is the discloser making | NO | |||||
disclosures in respect of any other party to the offer? | |||||||
2. | POSITIONS OF THE PERSON MAKING THE DISCLOSURE | ||||||
(a) | Interests and short positions in the relevant securities of the offeror or offeree | ||||||
to which the disclosure relates following the dealing(if any) | |||||||
Class of relevant security: | 5p ordinary | ||||||
Interests | Short Positions | ||||||
Number | (%) | Number | (%) | ||||
(1) | Relevant securities owned | ||||||
and/or controlled: | 4,685,201 | 2.12% | 2,611,990 | 1.18% | |||
(2) | Cash-settled derivatives: | ||||||
2,545,784 | 1.15% | 4,683,300 | 2.12% | ||||
(3) | Stock-settled derivatives (including options) | ||||||
and agreements to purchase/sell: | 0 | 0.00% | 0 | 0.00% | |||
TOTAL: | 7,230,985 | 3.28% | 7,295,290 | 3.30% | |||
(b) | Rights to subscribe for new securities (including directors and other executive | ||||||
options) | |||||||
Class of relevant security in relation to | |||||||
which subscription right exists | |||||||
Details, including nature of the rights | |||||||
concerned and relevant percentages: | |||||||
3. | DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE | ||||||
(a) | Purchases and sales | ||||||
Class of relevant | Purchase/sale | Number of | Price per unit | ||||
security | securities | ||||||
5p ordinary | Purchase | 29,953 | 2.7911 GBP | ||||
5p ordinary | Purchase | 17,935 | 2.7950 GBP | ||||
5p ordinary | Purchase | 10,890 | 2.7925 GBP | ||||
5p ordinary | Purchase | 9,912 | 2.7929 GBP | ||||
5p ordinary | Purchase | 9,555 | 2.7900 GBP | ||||
5p ordinary | Purchase | 7,992 | 2.7897 GBP | ||||
5p ordinary | Purchase | 983 | 2.7875 GBP | ||||
5p ordinary | Purchase | 983 | 2.7899 GBP | ||||
5p ordinary | Sale | 653,216 | 2.7950 GBP | ||||
5p ordinary | Sale | 3,280 | 2.7910 GBP | ||||
5p ordinary | Sale | 983 | 2.7900 GBP | ||||
5p ordinary | Sale | 983 | 2.7875 GBP | ||||
(b) | Cash-settled derivative transactions | ||||||
Class of | Product | Nature of dealing | Number of | Price per | |||
relevant | description | reference | unit | ||||
security | securities | ||||||
5p ordinary | SWAP | Decreasing Long | 10,500 | 2.7950 GBP | |||
5p ordinary | SWAP | Decreasing Long | 337 | 2.7902 GBP | |||
5p ordinary | SWAP | Decreasing Long | 275 | 2.7902 GBP | |||
5p ordinary | SWAP | Decreasing Long | 1 | 2.7950 GBP | |||
5p ordinary | SWAP | Decreasing Short | 157,566 | 2.7950 GBP | |||
5p ordinary | CFD | Increasing Short | 9,531 | 2.7902 GBP | |||
5p ordinary | CFD | Increasing Long | 144 | 2.7898 GBP | |||
5p ordinary | CFD | Opening Long | 470,049 | 2.7950 GBP | |||
5p ordinary | SWAP | Decreasing Long | 30 | 2.7940 GBP | |||
5p ordinary | SWAP | Increasing Short | 15,106 | 2.7918 GBP | |||
5p ordinary | CFD | Increasing Short | 22,435 | 2.7901 GBP | |||
5p ordinary | SWAP | Decreasing Short | 715 | 2.7950 GBP | |||
(c) | Stock-settled derivative transactions (including options) | ||||||
(i) | Writing, selling, purchasing or varying | ||||||
Class | Product | Writing, | Number | Exercise | Type | Expiry | Option |
of | description | purchasing, | of | price | date | money | |
relevant | selling, | securities | per unit | paid/ | |||
security | varying etc | to which | received | ||||
option | per unit | ||||||
relates | |||||||
(ii) | Exercise | ||||||
Class of relevant | Product description | Exercising/ exercised against | Number of | Exercise price per | |||
security | securities | unit | |||||
(d) | Other dealings (including subscribing for new securities) | ||||||
Class of relevant | Nature of Dealings | Details | Price per unit (if | ||||
security | applicable) | ||||||
4. | OTHER INFORMATION | ||||||
(a) | Indemnity and other dealings arrangements | ||||||
Details of any indemnity or option arrangement, or any agreement or understanding, | |||||||
formal or informal, relating to relevant securities which may be an inducement to deal | |||||||
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party | |||||||
to the offer or any person acting in concert with a party to the offer: | |||||||
NONE | |||||||
(b) | Agreements, arrangements or understandings relating to options or derivatives | ||||||
Details of any agreement, arrangement or understanding, formal or informal, between | |||||||
the person making the disclosure and any other person relating to: | |||||||
(i) the voting rights of any relevant securities under any option; or | |||||||
(ii) the voting rights of future acquisition or disposal of any relevant securities to which | |||||||
any derivative is referenced: | |||||||
NONE | |||||||
(c) | Attachments | ||||||
Is a Supplemental Form 8 (Open Positions) attached? | NO | ||||||
Date of disclosure: | 17 Jul 2026 | ||||||
Contact name: | Large Holdings Regulatory Operations | ||||||
Telephone number: | 020 3134 7213 | ||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END RETFZGMNMNZGVZM
